PABLO LUIS
ORTIZ ROMERO
Catedrático de universidad
Complejo Hospitalario de Toledo
Toledo, EspañaPublicaciones en colaboración con investigadores/as de Complejo Hospitalario de Toledo (7)
2020
-
Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways
British Journal of Dermatology, Vol. 182, Núm. 1, pp. 147-155
2017
-
Shared Oncogenic Pathways Implicated in Both Virus-Positive and UV-Induced Merkel Cell Carcinomas
Journal of Investigative Dermatology, Vol. 137, Núm. 1, pp. 197-206
2014
-
PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases
PLoS ONE, Vol. 9, Núm. 11
2013
-
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas
Haematologica, Vol. 98, Núm. 1, pp. 57-64
2004
-
Posible implicación de las alteraciones moleculares de la vía de TNF en la tumorigénesis de la micosis fungoide. Descripción de un posible chip de diagnóstico molecular en micosis fungoide
Actas Dermo-Sifiliograficas, Vol. 95, Núm. 2, pp. 86-96
2002
-
p16INK4a is selectively silenced in the tumoral progression of mycosis fungoides
Laboratory Investigation, Vol. 82, Núm. 2, pp. 123-132
2000
-
p16INK4a gene alterations are frequent in lesions of mycosis fungoides
American Journal of Pathology, Vol. 156, Núm. 5, pp. 1565-1572